Active, not recruitingNot applicableInterventional
What this study is about
The current project aims at evaluating the feasibility and efficacy of a multi-disciplinary weight loss program, using an innovative and simple dietary intervention at the American University of Beirut Medical Center (AUB-MC). Such intervention is expected to enhance patients' compliance and adherence to lifestyle changes. In addition, the program includes supervised exercise sessions and behavioral therapy. Therefore, our project proposes an evidence based approach to close the obesity treatment gaps.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to Not listed
SexAll
Healthy volunteersAccepted
ConditionObesity, Weight Loss
Full registry criteria
Inclusion Criteria: * Lebanese adult with obesity (≥18 years), obesity being defined as BMI ≥ 30 kg/m2 * Patients who can commit to frequent visit trials as per study protocol * Patients not traveling outside Lebanon for at least the 6-month period of the trial * Patients tolerating Metformin after a run-in period of 2 weeks Exclusion Criteria: * Patients who have taken other weight reducing drug therapy in the previous 6 months * Patients who have undergone bariatric therapy or endoscopic procedure, or planning to do so in the near future (at \< 6 months) * Patients with diabetes * Patients working at AUB-MC, as we will not be able to assess the adherence to study visits nor the feasibility of such a program in the general population, presenting to AUB-MC only for clinical care * A family member of a patient already enrolled in the study, as the participants will not be independent * Pregnant obese patients * Patients with pacemakers * Patients known to have hypertension, cardiac, pulmonary, renal or liver disease, active cancer or psychiatric illnesses * History of any surgery of less than 6 weeks duration * Patients known to have disabling osteoarthritic or orthopedic problems * Patients secondary uncontrolled endocrine disorders (thyroid disorders, polycystic ovary, Cushing disease), or drug induced obesity (such as anti-psychotic, steroids, hormonal therapy).
